Considering Data Qualities in Determining FFP - Can We Converge on an Approach?
Author(s)
Moderator: Marc L. Berger, MD, Marc L. Berger, LLC, New York, NY, USA
Speakers: John Concato, MD, MS, MPH, Food and Drug Administration, Silver Spring, MD, USA; Gracy Crane, PhD, Roche Products Limited, Welwyn, HRT, UK; Laurie Jean Lambert, PhD, Canadian Agency for Drugs and Technologies in Health, Ottawa, ON, Canada; Daniel Leaver Morales, -, EMA, Amsterdam, Netherlands
Presentation Documents
This session will be focused on the principles and realities of how fit-for-purpose decisions are made based on the needs of the study question and the qualities of the data. It will be primarily a panel discussion, considering questions such as “How does the study question interact with data qualities to determine what’s fit-for-purpose”?
Conference/Value in Health Info
2023-5, ISPOR Real-World Evidence Summit 2023, Boston, MA, USA
Topic
Real World Data & Information Systems